Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AD Calcineurin inhibitors
L04AD03 Voclosporin
D09033 Voclosporin (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Immunosuppressants
Calcineurin Inhibitors
Voclosporin
D09033 Voclosporin (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D09033 Voclosporin (JAN/USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG03129 Calcineurin inhibitor
D09033 Voclosporin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09033 Voclosporin
Drug classes [BR:br08332]
Immunological agent
DG03129 Calcineurin inhibitor
D09033 Voclosporin
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphatases
PPP3C/PPP3R/CHP
D09033 Voclosporin (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09033
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09033
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09033
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09033
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09033